Grazoprevir/elbasvir
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy
... treatment. Grazoprevir/elbasvir provides high rates of efficacy and tolerability and is an all-oral once daily treatment option for HCV ...of grazoprevir/elbasvir has been proven in patients ...
10
<p>A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants</p>
... of Elbasvir 50 mg/Grazoprevir 100 mg Fixed-Dose Combination in Healthy Chinese Participants (MK-5172-PN071) versus Grazoprevir (100 mg) or Elbasvir (50 mg) as Single-Entity Formulations in ...
11
SIMULTANEOUS REVERSE PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF GRAZOPREVIR AND ELBASVIR
... of grazoprevir and elbasvir in bulk drug and in pharmaceutical dosage ...of grazoprevir and elbasvir in bulk and tablet dosage form using Acquity UPLC HSS C18 (100 × ...of grazoprevir ...
5
The Efficacy and Safety of the Combination of Elbasvir/Grazoprevir In the Treatment of Chronic Hepatitis C Virus Infection: A Systematic Review of Clinical Trials
... Elbasvir (EBR) and grazoprevir (GZR) are new direct-acting antivirals for patients with hepatitis C virus (HCV) infection. This systematic review aimed to investigate the efficacy and safety of this ...
7
A NOVEL STABILITY INDICATING RP HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ANTI VIRAL CLASS OF ELBASVIR AND GRAZOPREVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
... of Elbasvir and Grazoprevir in bulk and pharmaceutical dosage ...of Elbasvir and Grazoprevir in the pharmaceutical dosage ...for Elbasvir and Grazoprevir were obtained to be NLT ...
6
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
... of elbasvir/ grazoprevir (EBR/GZR) treatment versus sofosbuvir with pegylated interferon and ribavirin (SOF/PR) on changes in PROs: 1) during the treatment period and 2) at posttreatment ...
8
<p>Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial</p>
... Hepatitis C virus (HCV) infection is a major healthcare con- cern in Russia, representing the third leading cause of death from infections after AIDS and tuberculosis. 1 The prevalence of HCV infection is 3.3% of the ...
8
Efficacy and Safety of Elbasvir/Grazoprevir Combination Therapy for Chronic Hepatitis C
... III trial of combination therapy with SOF and LDV in Japan resulted in a remarkable success in the achievement of sustained viral responses (SVR) due to an additive effect of the two drugs [16]. Despite of extremely high ...
5
Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence
... inhibitor elbasvir (EBR) and the HCV NS3/4A protease inhibitor grazoprevir (GZR) was approved for the treatment of patients with chronic HCV and genotypes (Gts) 1 and 4 in various ...
8
DEVELOPMENT AND VALIDATION OF NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMS
... namely Elbasvir and Grazoprevir in bulk and tablet dosage forms by make use of waters symmetry Shield C18 column , ...of Grazoprevir and Elbasvir was found to be ...of Elbasvir and ...
10
Development and validation of stability indicating RP-HPLC method for the estimation of Elbasvir and Grazoprevir in bulk and pharmaceutical dosage form
... In the present study Performed with Waters HPLC 2695 Photo diode array detector and Empower 2 software was used UV-Visible spectrophotometer PG Instruments T60 with special bandwidth of 2 mm and10mm and matched quartz ...
9
“Stability Indicating Validated RP-UPLC Method for Simultaneous Determination of Elbasvir and Grazoprevir in Bulk and Pharmaceutical Dosage Form” by N. Madana Gopal, C. Sridhar, India.
... of elbasvir and grazoprevir in bulk and in combined tablet dosage ...of elbasvir and grazoprevir was achieved within 5 minutes on an oligonucleotide C18 (50 mm x ...for elbasvir and ...
6
RP HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF GRAZOPREVIR AND ELBASVIR IN BULK AND ITS DOSAGE FORM WITH STRESS STUDIES
... Grazoprevir and Elbasvir, respectively. Quantification is achieved with PDA detection at 254 nm over the concentration range of 50–150 μg/ml for Grazoprevir and for Elbasvir 25–125 μg/ml, with ...
13
Spotlight on grazoprevir—elbasvir once-daily combination and its potential in the treatment of hepatitis C
... Abstract: Chronic hepatitis C virus (HCV) infection is a leading cause of health care utilization in the USA. Incidence of cirrhosis from HCV is expected to rise in the near future, further increasing this burden. There ...
9
<p>Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy</p>
... of elbasvir (EBR) 50 mg/ grazoprevir (GZR) 100 mg is approved in the United States, Europe, and other countries worldwide for the treatment of people with HCV genotype (GT) 1 or GT4 ...
12